We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSNC icon
26
SS&C Technologies
SSNC
$18.7B
$184M 0.89%
2,998,144
+412,175
+16% +$23.1M
CI icon
27
Cigna
CI
$72.7B
$183M 0.88%
894,988
+737,631
+469% +$135M
ABBV icon
28
AbbVie
ABBV
$431B
$181M 0.87%
2,039,761
+784,623
+63% +$65.1M
EA
29
DELISTED
Electronic Arts
EA
$177M 0.85%
1,642,066
+422,043
+35% +$41.9M
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.38T
$167M 0.81%
2,499,860
+1,090,000
+77% +$70.3M
FISV
31
Fiserv Inc
FISV
$28.9B
$162M 0.78%
1,396,963
-217,024
-13% -$24M
IQV icon
32
IQVIA
IQV
$38.3B
$159M 0.77%
1,028,474
+135,662
+15% +$19.8M
SPGI icon
33
S&P Global
SPGI
$119B
$148M 0.71%
541,761
-90,371
-14% -$23.5M
COST icon
34
Costco
COST
$421B
$145M 0.7%
494,205
+172,791
+54% +$51.4M
PNR icon
35
Pentair
PNR
$11.2B
$142M 0.69%
3,096,646
-453,909
-13% -$19.2M
MRK icon
36
Merck
MRK
$317B
$141M 0.68%
1,619,027
-372,833
-19% -$30.6M
AVGO icon
37
Broadcom
AVGO
$2T
$135M 0.65%
4,269,710
+895,170
+27% +$27.2M
AVY icon
38
Avery Dennison
AVY
$13.2B
$135M 0.65%
1,029,760
-480,282
-32% -$60.6M
PYPL icon
39
PayPal
PYPL
$51.1B
$134M 0.65%
1,238,839
-8,928
-0.7% -$930K
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$123B
$129M 0.62%
589,318
-163,350
-22% -$33.1M
NSC icon
41
Norfolk Southern
NSC
$76.9B
$128M 0.62%
658,614
+215,479
+49% +$40.4M
VAR
42
DELISTED
Varian Medical Systems, Inc.
VAR
$124M 0.6%
874,525
+716,309
+453% +$91.4M
QSR icon
43
Restaurant Brands International
QSR
$25.4B
$120M 0.58%
1,889,326
+548,542
+41% +$36.7M
AVTR icon
44
Avantor
AVTR
$8.91B
$117M 0.56%
6,436,545
+1,165,338
+22% +$18.5M
KEYS icon
45
Keysight
KEYS
$57.6B
$112M 0.54%
1,086,625
+427,629
+65% +$43.8M
TSM icon
46
TSMC
TSM
$2.17T
$110M 0.53%
1,888,481
+419,440
+29% +$22.2M
DHR icon
47
Danaher
DHR
$141B
$109M 0.53%
803,359
-846,172
-51% -$107M
SNPS icon
48
Synopsys
SNPS
$77.7B
$108M 0.52%
772,636
+435,983
+130% +$59.8M
MU icon
49
Micron Technology
MU
$996B
$107M 0.52%
1,992,460
-1,368,074
-41% -$65.3M
AZN icon
50
AstraZeneca
AZN
$250B
$107M 0.52%
1,070,683
-635,155
-37% -$59.8M
1
2
3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.